Actinium Pharmaceuticals, Inc.
ATNM
$1.52
-$0.03-1.94%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -45.51M | -38.24M | -40.92M | -42.62M | -46.45M |
| Total Depreciation and Amortization | 800.00K | 811.00K | 806.00K | 804.00K | 824.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.79M | 5.29M | 5.02M | 4.60M | 4.23M |
| Change in Net Operating Assets | -1.35M | -932.00K | 282.00K | 3.26M | 1.77M |
| Cash from Operations | -33.27M | -33.07M | -34.81M | -33.96M | -39.63M |
| Capital Expenditure | 0.00 | -11.00K | -11.00K | -41.00K | -88.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -11.00K | -11.00K | -41.00K | -88.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.00K | -9.00K | -8.00K | -7.00K | -5.00K |
| Issuance of Common Stock | 14.56M | 29.33M | 30.52M | 28.78M | 28.87M |
| Repurchase of Common Stock | -1.00K | -1.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.55M | 29.32M | 30.52M | 28.77M | 28.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.72M | -3.76M | -4.31M | -5.23M | -10.85M |